Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.

about

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data.Natural Conformational Sampling of Human TNFα Visualized by Double Electron-Electron Resonance.

P2860

Q31167447-95E01ED9-176D-4FAF-8E4D-B51752492076 Q48024823-16465056-004B-41C7-9574-FF2C9D657683

P2860

Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.

Item

http://www.wikidata.org/entity/Q38404761

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Long-term drug survival of bio ...... rthritis in clinical practice.

@en

type

Item

label

Long-term drug survival of bio ...... rthritis in clinical practice.

@en

prefLabel

Long-term drug survival of bio ...... rthritis in clinical practice.

@en

P1476

Long-term drug survival of bio ...... rthritis in clinical practice.

@en

P2093

A Gomez

http://www.w3.org/2001/XMLSchema#string

E Pato

http://www.w3.org/2001/XMLSchema#string

J A Jover

http://www.w3.org/2001/XMLSchema#string

J R Lamas

http://www.w3.org/2001/XMLSchema#string

L Abasolo

http://www.w3.org/2001/XMLSchema#string

L Leon

http://www.w3.org/2001/XMLSchema#string

L Rodriguez-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Z Rosales

http://www.w3.org/2001/XMLSchema#string

P2860

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.

Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.

The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.

Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug Registers.

Changing patterns of tumor necrosis factor inhibitor use in 9074 patients with rheumatoid arthritis.

Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.

Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide D

Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register.

P304

456-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03009742.2016.1141979

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27115843

http://www.w3.org/2001/XMLSchema#string

Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.

about

P2860

P2860

Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698